Assertio Holdings agreed to be acquired by Garda Therapeutics for $125.1 million in cash. The pharmaceutical company also said it signed and closed an agreement to sell all non-Rolvedon assets to ...

In connection with the deal, Assertio has divested the rest of its assets to New Jersey generics and branded drugmaker ...

Cosette Pharmaceuticals, Inc., a U.S.-based, branded specialty pharmaceutical company, announced today the closing of a definitive agreement to acquire the U.S. sales and distribution rights for a ...

Plus Contingent Value RightTender Offer Price Represents 34.6% Premium to Unaffected Price and 46.6% Premium to Unaffected 30-day Volume-Weighted Average PriceTransaction Follows Comprehensive ...

Assertio (ASRT) closed the last trading session at $18.41, gaining 60.1% over the past four weeks, but there could be plenty ...

US specialty pharma company Cosette Pharmaceuticals announced the closing of a definitive agreement to acquire the US sales ...

Shares of Assertio Holdings, Inc. (ASRT) fell 1.5% after hours on Wednesday after the company said that it has entered into ...

Illinois, USA-based Assertio Holdings yesterday announced a definitive agreement to be acquired by Garda Therapeutics for $18 ...

LAKE FOREST, Ill.--(BUSINESS WIRE)--Assertio Holdings, Inc. (“Assertio”) (Nasdaq: ASRT) today announced that it will release fourth quarter and full year 2025 financial results on Monday, March 16, ...

Assertio Holdings showed Q1 2023 net product sales increase of 18%, despite reporting a net loss due to increased expenses. Assertio's growth strategy involves expanding product range through ...

Cosette Pharmaceuticals, Inc., a U.S.-based, branded specialty pharmaceutical company, announced today the closing of a ...